HealthPhoto: CRISPR Medicine NewsPrime Medicine Starts First In-Body Prime Editing Trial for Wilson Disease
Prime Medicine has launched the first in-body prime editing clinical trial targeting Wilson disease. This groundbreaking trial uses CRISPR technology to rewrite DNA directly inside a patient's body, marking a significant advancement in gene editing therapies. The trial aims to correct genetic mutations causing Wilson disease, a rare inherited disorder. This development was reported in the CMN Weekly on 23 October 2026.
CRISPR Medicine News·


